FDA Drug Application (020873) for ANGIOMAX by THE MEDICINES CO

Back to FDA Applications sponsored by THE MEDICINES CO

Application Number020873
Product Number001
FormINJECTABLE;INTRAVENOUS
Dosage250MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameANGIOMAX
Active IngredientBIVALIRUDIN



Back to FDA Applications sponsored by THE MEDICINES CO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.